FINWIRES · TerminalLIVE
FINWIRES

根據最近提交給美國證券交易委員會（SEC）的文件顯示，Meta Platforms內部人士出售了價值1,043,156美元的股票。

By

-- 營運長哈維爾·奧利萬 (Javier Olivan) 於 2026 年 4 月 27 日出售了 Meta Platforms (META) 的 1,555 股股票，套現 1,043,156 美元。根據向美國證券交易委員會 (SEC) 提交的 4 號表格文件，奧利萬目前控制該公司共計 112,522 股 A 類普通股，其中 8,705 股為直接持有，103,817 股為間接控制。 SEC 文件連結： https://www.sec.gov/Archives/edgar/data/1326801/000095010326006451/xslF345X05/ownership.xml

Related Articles

Asia

Joinn Laboratories Grants 1.4 Million Award Shares Under 2022 Scheme

Joinn Laboratories (SHA:603127, HKG:6127) granted a little over 1.4 million award shares to 12 participants under a 2022 share incentive scheme, according to a Thursday Hong Kong bourse filing.Of the total, 500,00 shares were granted to Chair Feng Yuxia, with the others being offered to directors and managers of the group.

$HKG:6127$SHA:603127
Sectors

Sector Update: Financial Stocks Decline Pre-Bell Thursday

Financial stocks were declining pre-bell Thursday, with the State Street Financial Select Sector SPDR ETF (XLF) down 0.6%.The Direxion Daily Financial Bull 3X Shares (FAS) was 1.9% lower and its bearish counterpart Direxion Daily Financial Bear 3X Shares (FAZ) was up 1.9%.Banco Bilbao Vizcaya Argentaria (BBVA) stock was up more than 2% after the company reported higher Q1 adjusted earnings and gross income.ING Groep (ING) shares were up more than 2% after the company posted higher Q1 earnings and total income.Willis Towers Watson (WTW) stock was down more than 9% even after the company posted higher Q1 adjusted earnings and revenue.

$BBVA$FAS$FAZ$ING$WTW$XLF
Sectors

Sector Update: Health Care Stocks Rise Premarket Thursday

Health care stocks were rising premarket Thursday, with the State Street Health Care Select Sector SPDR ETF (XLV) 1% higher and the iShares Biotechnology ETF (IBB) up 0.6%.Eli Lilly (LLY) shares were up more than 5% after the company reported higher Q1 non-GAAP earnings and revenue, and raised its 2026 outlook.Merck (MRK) stock was down more than 1% after the company said it swung to a Q1 adjusted loss.Alnylam Pharmaceuticals (ALNY) shares were up more than 2% after the company posted higher Q1 adjusted net income and revenue.

$ALNY$IBB$LLY$MRK$XLV